$11.49
+0.37 (+3.33%)
Open$11.14
Previous Close$11.12
Day High$11.58
Day Low$11.14
52W High$22.55
52W Low$10.42
Volume—
Avg Volume282.0K
Market Cap230.33M
P/E Ratio2.65
EPS$1.82
SectorBiotechnology
Analyst Ratings
Buy
15 analysts
Price Target
+71.5% upside
Current
$11.49
$11.49
Target
$19.70
$19.70
$13.49
$19.70 avg
$20.36
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 129.23M | 4.38M | 103.26M |
| Net Income | 46.07M | -207,966,613 | -15,524,708 |
| Profit Margin | 35.7% | -5,013.7% | -15.0% |
| EBITDA | 36.29M | -245,260,567 | -22,220,211 |
| Free Cash Flow | — | — | -17,331,210 |
| Rev Growth | — | -43.9% | +11.8% |
| Debt/Equity | — | — | 0.46 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |